An interventional study of Repetitive transcranial magnetic stimulation in Isolated Focal Hand Dystonia, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-13.
Sponsored by Duke University · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Dystonia, Focal, Task-Specific with a site in United States — 1 open to participants now, 3 under way, none of them phase 3. Dystonia, Focal, Task-Specific · United States.
Among the 21 studies in Dystonia, Focal, Task-Specific with a site in United States, this one is one of 2 that started in 2018, is one of 3 with no phase, and was the 21st registered.
26 studies on the registry are indexed under Dystonia, Focal, Task-Specific; 3 are open to participants now.
Browse Dystonia, Focal, Task-Specific studies →1 of the 21 studies in Dystonia, Focal, Task-Specific with a site in United States is open now. Recruiting first, the newest first:
University of Maryland, Baltimore · Sites in United States
Ages 21–75
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 2 Dystonia, Focal, Task-Specific studies recruiting now, 1 sets no upper age limit and 1 stops at 75 or younger; none take children under 18; none take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 5
First in 2001; this study’s year is marked. 2 started in 2018.
This study's enrollment of 12 is below the median of 15 across 13 interventional studies indexed under Dystonia, Focal, Task-Specific.
Median enrollment 12 across the 9 interventional studies, 56 across the 12 observational. Of the 18 that completed or were terminated, 4 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 21 has an industry lead sponsor. The 5 most frequent:
Duke University is the lead sponsor of 2,064 studies on the registry; 271 are open to participants now.
Of its 204 completed or terminated interventional studies of FDA-regulated products, 170 (83%) have results posted.
Duke University has 2 studies filed under Dystonia, Focal, Task-Specific — fewer than ten, so there is no comparison to draw.
2 of the studies in Dystonia, Focal, Task-Specific with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06015672Duke UniversityAccelerated TMS for Focal Hand Dystonia | 2027-02-05 |
| NCT06367608University of Maryland, BaltimoreMRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD) | 2027-06 |
Add all 2 to your calendar (.ics) → With an account.
Among the 21 studies in Dystonia, Focal, Task-Specific with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to apply a non-invasive brain stimulation technology called repetitive Transcranial Magnetic Stimulation (rTMS) in patients with focal hand dystonia (FHD). The goal of the study is to identify which cortical target (premotor cortex (PMC) or primary somatosensory cortex (PSC)) will show benefit after active rTMS compared to sham rTMS. A secondary goal of the study is to understand if 10 Hz rTMS can show behavioral benefit compared to sham rTMS. The study will evaluate rTMS response using measures if writing on a sensor tablet, examiner and patient dystonia rating scales and brain imaging scan (functional MRI) to understand brain changes after rTMS. Safety measures include adherence to TMS guidelines and thorough medical screening to prevent seizures.
The primary objective of this study is to develop rTMS for FHD. The focus is to assess whether stimulating the PMC or PSC will show greater improvement in writing behavior. This research builds upon prior studies that have demonstrated improvement in behavior after rTMS to PMC and PSC. The study includes five sequential visits:
The information in this record reflects Visits 3-5
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Healthy Control Participants:
Focal Hand dystonia Patients:
Exclusion Criteria:
Healthy Control Participants (visits 2, 3, 4, and 5) and Focal Hand dystonia Patients (visits 2, 3, 4, and 5):
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
10 Hz rTMS to premotor cortex
Device: Repetitive transcranial magnetic stimulation
10 Hz rTMS to primary somatosensory cortex
Device: Repetitive transcranial magnetic stimulation
0.7 Hz rTMS to premotor cortex
Device: Repetitive transcranial magnetic stimulation
10 Hz repetitive TMS will be delivered for 20 minutes per session and 0.7 Hz for 20 minutes per session
Feasibility of Accurately Delivering TMS During the Task of Writing as Measured by Number of Participants Who Completed the TMS Sessions
Time frame: Pre-TMS and post-TMS session (each session is approximately 45 minutes)
Safety, as Measured by TMS Acute Side Effects
Time frame: During TMS session (each session is approximately 45 minutes)
Change in Peak Accelerations Behavior (Calculated by Taking the Change in Peak Accelerations From Behavior Performed Before and After Each TMS Visit).
Change in peak accelerations behaviors pre- and post-TMS is calculated by taking the change in peak accelerations from behavior performed before and after each TMS visit. Higher measures of peak accelerations represent greater writing dysfluency and worsening dystonia.
Time frame: Pre-TMS and post-TMS session (each session is approximately 45 minutes)
Brain Connectivity Between Superior Parietal Cortex to Right Cerebellum VIII
Brain connectivity was assessed using functional magnetic resonance imaging of the brain. The z-score is mathematical calculation of the synchronization between brain regions. Specifically, functional connectivity z-scores quantify the strength of synchronization between brain regions by transforming Pearson correlation coefficients (r-values) into normally distributed values (z-scores). This Fisher-z transformation stabilizes variance, enabling valid group-level statistical comparisons (e.g., t-tests) of functional connectivity. Positive Z-scores (Z scores\> 0) represent stronger synchronization between brain regions and strengthening of connectivity between brain regions; negative Z-scores (Z-scores \<0) indicate anti-synchronization between brain regions and weakening of connectivity between brain regions.
Time frame: Post-TMS session (each session is approximately 45 minutes)
| Milestone | PMC, PSC, Sham | PMC, Sham, PSC | PSC, PMC, Sham | Sham, PMC, PSC | PSC, Sham, PMC | Sham, PSC, PMC |
|---|---|---|---|---|---|---|
| Started | 2 | 2 | 2 | 2 | 2 | 2 |
| Completed | 2 | 2 | 2 | 2 | 2 | 2 |
| Not completed | 0 | 0 | 0 | 0 | 0 | 0 |
| Milestone | PMC, PSC, Sham | PMC, Sham, PSC | PSC, PMC, Sham | Sham, PMC, PSC | PSC, Sham, PMC | Sham, PSC, PMC |
|---|---|---|---|---|---|---|
| Started | 2 | 2 | 2 | 2 | 2 | 2 |
| Completed | 2 | 2 | 2 | 2 | 2 | 2 |
| Not completed | 0 | 0 | 0 | 0 | 0 | 0 |
| Milestone | PMC, PSC, Sham | PMC, Sham, PSC | PSC, PMC, Sham | Sham, PMC, PSC | PSC, Sham, PMC | Sham, PSC, PMC |
|---|---|---|---|---|---|---|
| Started | 2 | 2 | 2 | 2 | 2 | 2 |
| Completed | 2 | 2 | 2 | 2 | 2 | 2 |
| Not completed | 0 | 0 | 0 | 0 | 0 | 0 |
| Milestone | PMC, PSC, Sham | PMC, Sham, PSC | PSC, PMC, Sham | Sham, PMC, PSC | PSC, Sham, PMC | Sham, PSC, PMC |
|---|---|---|---|---|---|---|
| Started | 2 | 2 | 2 | 2 | 2 | 2 |
| Completed | 2 | 2 | 2 | 2 | 2 | 2 |
| Not completed | 0 | 0 | 0 | 0 | 0 | 0 |
| Milestone | PMC, PSC, Sham | PMC, Sham, PSC | PSC, PMC, Sham | Sham, PMC, PSC | PSC, Sham, PMC | Sham, PSC, PMC |
|---|---|---|---|---|---|---|
| Started | 2 | 2 | 2 | 2 | 2 | 2 |
| Completed | 2 | 2 | 2 | 2 | 2 | 2 |
| Not completed | 0 | 0 | 0 | 0 | 0 | 0 |
| Participants | rTMS to Premotor Cortex (PMC) | rTMS to Primary Somatosensory Cortex (PSC) | Sham rTMS |
|---|---|---|---|
| Feasibility of Accurately Delivering TMS During the Task of Writing as Measured by Number of Participants Who Completed the TMS Sessions | 12 | 12 | 11 |
| acute side affects | 10 Hz rTMS to Premotor Cortex | 10 Hz rTMS to Primary Somatosensory Cortex | Sham TMS |
|---|---|---|---|
| Safety, as Measured by TMS Acute Side Effects | 0 | 0 | 0 |
Change in peak accelerations behaviors pre- and post-TMS is calculated by taking the change in peak accelerations from behavior performed before and after each TMS visit. Higher measures of peak accelerations represent greater writing dysfluency and worsening dystonia.
| percentage of pre-TMS session | 10 Hz rTMS to Premotor Cortex | 10 Hz rTMS to Primary Somatosensory Cortex | Sham TMS |
|---|---|---|---|
| Change in Peak Accelerations Behavior (Calculated by Taking the Change in Peak Accelerations From Behavior Performed Before and After Each TMS Visit). | 99.00 ± 0.90 | 96.43 ± 1.39 | 100.06 ± 0.76 |
Brain connectivity was assessed using functional magnetic resonance imaging of the brain. The z-score is mathematical calculation of the synchronization between brain regions. Specifically, functional connectivity z-scores quantify the strength of synchronization between brain regions by transforming Pearson correlation coefficients (r-values) into normally distributed values (z-scores). This Fisher-z transformation stabilizes variance, enabling valid group-level statistical comparisons (e.g., t-tests) of functional connectivity. Positive Z-scores (Z scores\> 0) represent stronger synchronization between brain regions and strengthening of connectivity between brain regions; negative Z-scores (Z-scores \<0) indicate anti-synchronization between brain regions and weakening of connectivity between brain regions.
| z-score | 10 Hz rTMS to Premotor Cortex | 10 Hz rTMS to Primary Somatosensory Cortex | Sham TMS |
|---|---|---|---|
| Brain Connectivity Between Superior Parietal Cortex to Right Cerebellum VIII | 0.28 ± 0.03 | 0.27 ± 0.04 | 0.44 ± 0.03 |
Collected over The standard TMS adverse events survey was collected before and after each TMS session. Each session lasted about 45 minutes.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| rTMS to Premotor Cortex (PMC) | 0/12 (0%) | 0/12 (0%) | 0/12 (0%) |
| rTMS to Primary Somatosensory Cortex (PSC) | 0/12 (0%) | 0/12 (0%) | 0/12 (0%) |
| Sham rTMS | 0/12 (0%) | 0/12 (0%) | 0/12 (0%) |
| Age, Categorical(Participants) | PMC, PSC, Sham | PMC, Sham, PSC | PSC, PMC, Sham | Sham, PMC, PSC | PSC, Sham, PMC | Sham, PSC, PMC | Total |
|---|---|---|---|---|---|---|---|
| <=18 years | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Between 18 and 65 years | 2 | 2 | 0 | 1 | 2 | 2 | 9 |
| >=65 years | 0 | 0 | 2 | 1 | 0 | 0 | 3 |
| Sex: Female, Male(Participants) | PMC, PSC, Sham | PMC, Sham, PSC | PSC, PMC, Sham | Sham, PMC, PSC | PSC, Sham, PMC | Sham, PSC, PMC | Total |
|---|---|---|---|---|---|---|---|
| Female | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Male | 2 | 2 | 2 | 2 | 2 | 1 | 11 |
| Ethnicity (NIH/OMB)(Participants) | PMC, PSC, Sham | PMC, Sham, PSC | PSC, PMC, Sham | Sham, PMC, PSC | PSC, Sham, PMC | Sham, PSC, PMC | Total |
|---|---|---|---|---|---|---|---|
| Hispanic or Latino | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Not Hispanic or Latino | 1 | 2 | 2 | 2 | 2 | 2 | 11 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | PMC, PSC, Sham | PMC, Sham, PSC | PSC, PMC, Sham | Sham, PMC, PSC | PSC, Sham, PMC | Sham, PSC, PMC | Total |
|---|---|---|---|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Asian | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Black or African American | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| White | 2 | 2 | 2 | 2 | 2 | 2 | 12 |
| More than one race | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Unknown or Not Reported | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Region of Enrollment(participants) | PMC, PSC, Sham | PMC, Sham, PSC | PSC, PMC, Sham | Sham, PMC, PSC | PSC, Sham, PMC | Sham, PSC, PMC | Total |
|---|---|---|---|---|---|---|---|
| United States | 2 | 2 | 2 | 2 | 2 | 2 | 12 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Aug 2018 to primary completion in Jan 2023, 52 months.
Results were first posted in Apr 2026, 3 years 3 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dystonia, Focal, Task-Specific →